COVID-19 vaccination in individuals with inflammatory rheumatic diseases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36517627.
- Also identified by DOI 10.1038/s41584-022-00892-3 and PMC identifier 9748886.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since the start of the SARS-CoV-2 vaccination campaign, our knowledge of the effects of vaccines in people with inflammatory rheumatic diseases has remained incomplete. In particular, the effects of immunomodulatory therapies on vaccine success are poorly understood. Three notable papers from the past year have helped to fill these knowledge gaps.
Medical subject headings
- COVID-19
- Rheumatic Diseases